Market Overview:
The global nuclear imaging market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer and other diseases, growing demand for early diagnosis and treatment, and technological advancements in nuclear imaging devices. Oncology is the largest application segment of the global nuclear imaging market, owing to the high prevalence of cancer across the world. Cardiology is another major application segment of this market due to increasing incidence rates of cardiovascular diseases (CVDs). Other major application segments include neurology and others. North America dominates the global nuclear imaging market, followed by Europe and Asia Pacific. The growth in these regions can be attributed to rising geriatric population, growing awareness about early diagnosis and treatment options, increase in healthcare expenditure, and technological advancements in diagnostic devices.
Product Definition:
Nuclear Imaging is the process of using radioactive material (called a tracer) to create images of the body's organs and tissues. The images help doctors see how well the organs and tissues are working. Nuclear Imaging may also be used to find tumors or other abnormalities.
Positron Emission Tomography:
Positron emission tomography (PET) is a diagnostic procedure that utilizes a small quantity of radioactive tracer substance to observe the functioning of the targeted organ or tissue. The PET scan works by detecting and measuring radioactively labeled compounds, which are produced by certain body organs as they break down or decay quickly.
Single-photon Emission Computed Tomography:
Single-photon emission computed tomography (SPECT) is a nuclear imaging technique that utilizes gamma rays for diagnostic purposes. It works on the principle of detecting and mapping the distribution of radioisotopes in tissues using special cameras and detectors. SPECT has several advantages over other radiographic techniques as it does not use ionizing radiation, which makes it suitable for medical imaging across various ages including neonates, children, adults and pregnant women.
Application Insights:
The others application segment includes musculoskeletal, oncology, cardiology, neurology and other applications. In 2017, the others application segment dominated the global nuclear imaging market with a share of over 40% in terms of revenue. The growth can be attributed to an increase in demand for NNI solutions across various clinical applications such as oncology (cancer), cardiology (heart disease), neurology (brain tumor) and musculoskeletal disorders.
Oncology is expected to be one of the fastest-growing segments during the forecast period due to factors such as increasing incidence rates for cancer across various regions coupled with rising adoption of nuclear medicine solutions by healthcare providers for diagnostic purposes.
Regional Analysis:
North America dominated the global nuclear imaging market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies, and favorable reimbursement policies. The U.S., which is at the forefront of this regional market, has a well-developed healthcare infrastructure that makes it one of the most attractive markets for global nuclear imaging providers to invest in or establish their business operations.
Asia Pacific is expected to grow at an exponential rate during the forecast period owing to increasing government initiatives for improving healthcare facilities and services coupled with rising awareness about nuclear scans among patients in emerging countries such as China and India thereby driving demand over the next eight years.
Growth Factors:
- Increasing incidence of cancer and other diseases that can be diagnosed through nuclear imaging
- Growing demand for early diagnosis and treatment of various diseases
- Rising awareness about the benefits of nuclear imaging technology
- Technological advancements in nuclear imaging equipment and software
- Growing number of private clinics and hospitals offering nuclear imaging services
Scope Of The Report
Report Attributes
Report Details
Report Title
Nuclear Imaging Market Research Report
By Type
Positron Emission Tomography, Single-photon Emission Computed Tomography, Planar Scintigraphy Systems
By Application
Oncology, Cardiology, Neurology, Others
By Companies
GE, Siemens Healthcare, Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical, Digirad, DDD-Diagnostics, Neusoft Medical Systems, Mediso, SurgicEye, CMR Naviscan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Nuclear Imaging Market Report Segments:
The global Nuclear Imaging market is segmented on the basis of:
Types
Positron Emission Tomography, Single-photon Emission Computed Tomography, Planar Scintigraphy Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiology, Neurology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE
- Siemens Healthcare
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Medical
- Digirad
- DDD-Diagnostics
- Neusoft Medical Systems
- Mediso
- SurgicEye
- CMR Naviscan
Highlights of The Nuclear Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Positron Emission Tomography
- Single-photon Emission Computed Tomography
- Planar Scintigraphy Systems
- By Application:
- Oncology
- Cardiology
- Neurology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nuclear Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nuclear imaging is a medical procedure that uses radiation to create images of the body. Nuclear imaging can be used to diagnose and treat conditions such as cancer, heart disease, and arthritis.
Some of the major companies in the nuclear imaging market are GE, Siemens Healthcare, Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical, Digirad, DDD-Diagnostics, Neusoft Medical Systems, Mediso, SurgicEye, CMR Naviscan.
The nuclear imaging market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nuclear Imaging Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nuclear Imaging Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nuclear Imaging Market - Supply Chain
4.5. Global Nuclear Imaging Market Forecast
4.5.1. Nuclear Imaging Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nuclear Imaging Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nuclear Imaging Market Absolute $ Opportunity
5. Global Nuclear Imaging Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nuclear Imaging Market Size and Volume Forecast by Type
5.3.1. Positron Emission Tomography
5.3.2. Single-photon Emission Computed Tomography
5.3.3. Planar Scintigraphy Systems
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nuclear Imaging Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nuclear Imaging Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Cardiology
6.3.3. Neurology
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nuclear Imaging Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nuclear Imaging Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nuclear Imaging Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nuclear Imaging Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nuclear Imaging Demand Share Forecast, 2019-2026
9. North America Nuclear Imaging Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nuclear Imaging Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nuclear Imaging Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Cardiology
9.4.3. Neurology
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nuclear Imaging Market Size and Volume Forecast by Type
9.7.1. Positron Emission Tomography
9.7.2. Single-photon Emission Computed Tomography
9.7.3. Planar Scintigraphy Systems
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nuclear Imaging Demand Share Forecast, 2019-2026
10. Latin America Nuclear Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nuclear Imaging Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nuclear Imaging Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Cardiology
10.4.3. Neurology
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nuclear Imaging Market Size and Volume Forecast by Type
10.7.1. Positron Emission Tomography
10.7.2. Single-photon Emission Computed Tomography
10.7.3. Planar Scintigraphy Systems
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nuclear Imaging Demand Share Forecast, 2019-2026
11. Europe Nuclear Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nuclear Imaging Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nuclear Imaging Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Cardiology
11.4.3. Neurology
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nuclear Imaging Market Size and Volume Forecast by Type
11.7.1. Positron Emission Tomography
11.7.2. Single-photon Emission Computed Tomography
11.7.3. Planar Scintigraphy Systems
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nuclear Imaging Demand Share, 2019-2026
12. Asia Pacific Nuclear Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nuclear Imaging Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nuclear Imaging Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Cardiology
12.4.3. Neurology
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nuclear Imaging Market Size and Volume Forecast by Type
12.7.1. Positron Emission Tomography
12.7.2. Single-photon Emission Computed Tomography
12.7.3. Planar Scintigraphy Systems
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nuclear Imaging Demand Share, 2019-2026
13. Middle East & Africa Nuclear Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nuclear Imaging Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nuclear Imaging Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Cardiology
13.4.3. Neurology
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nuclear Imaging Market Size and Volume Forecast by Type
13.7.1. Positron Emission Tomography
13.7.2. Single-photon Emission Computed Tomography
13.7.3. Planar Scintigraphy Systems
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nuclear Imaging Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nuclear Imaging Market: Market Share Analysis
14.2. Nuclear Imaging Distributors and Customers
14.3. Nuclear Imaging Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Philips Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Toshiba Medical Systems Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hitachi Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Digirad
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DDD-Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Neusoft Medical Systems
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mediso
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SurgicEye
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CMR Naviscan
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
